Related Experiment Video

Updated: Jul 14, 2026

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs
08:58

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs

Published on: October 31, 2025

Glucose regulation in preterm newborn infants

Delphine Mitanchez1

  • 1Université Pierre et Marie Curie, Faculté de Médecine, Service de néonatologie, AP-HP, Hôpital Armand-Trousseau, Paris, France. delphine.mitanchez@trs.ap-hop-paris.fr

Hormone Research
|June 26, 2007
PubMed

Insights

Preterm infants struggle with glucose regulation after birth, often experiencing abnormal blood sugar levels. Insulin therapy can help manage glucose production in these vulnerable newborns.

Area of Science:

  • Neonatalogy
  • Endocrinology
  • Metabolic Research

Background:

  • Postnatal adaptation requires neonates to maintain glucose homeostasis independently.
  • Preterm infants face significant risks of glucose dysregulation due to immature metabolic systems and limited energy stores.
  • Abnormal glucose homeostasis, including hypoglycemia and hyperglycemia, is common in preterm neonates.

Purpose of the Study:

  • To investigate the challenges in glucose homeostasis in preterm infants.
  • To explore the causes of hyperglycemia in preterm neonates receiving glucose infusions.
  • To evaluate the efficacy and safety of insulin therapy for managing glucose levels in preterm infants.

Main Methods:

  • Observational analysis of glucose metabolism in preterm infants.
  • Assessment of hormonal and metabolic adaptive changes.
  • Evaluation of response to continuous glucose infusion and exogenous insulin therapy.

Main Results:

  • Preterm infants exhibit impaired glucose homeostasis, with a high incidence of hypoglycemia and hyperglycemia.
  • Hyperglycemia in preterm infants may be linked to defective proinsulin processing and partial insulin resistance.
  • Exogenous insulin infusion partially suppresses hepatic glucose production in preterm neonates, demonstrating efficacy with caution.

Conclusions:

  • Preterm infants require careful glucose management due to unique metabolic challenges.
  • Insulin therapy is a potentially safe and effective strategy for managing hyperglycemia in preterm neonates.
  • Further research is essential to elucidate the specific mechanisms of glucose homeostasis in preterm infants and the long-term effects of nutritional support.

More Related Videos

Transcutaneous Microcirculatory Imaging in Preterm Neonates06:27

Transcutaneous Microcirculatory Imaging in Preterm Neonates

Published on: December 31, 2015

Related Concept Videos

Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Glucose Absorption Into the Small Intestine01:26

Glucose Absorption Into the Small Intestine

Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and 'exit' via the...